TY - JOUR
T1 - Serum/saliva correlations for theophylline in asthmatics
AU - Blanchard, J.
AU - Harvey, S.
AU - Morgan, W. J.
PY - 1991
Y1 - 1991
N2 - Theophylline levels in mixed saliva (both stimulated and unstimulated) were compared with total and free (unbound) serum theophylline levels in 28 asthmatic outpatients using theophylline regularly. Stimulated saliva predicted both total and unbound serum theophylline concentrations within ± 1 μg/mL in 62.5% and 92.9%, respectively, of the samples examined. In addition, the total serum levels could be used to predict unbound serum concentrations to within ± 1 mg/L in 100% of the cases that were examined. These results indicate that saliva levels predict the unbound serum theophylline levels with greater accuracy and precision than they predict total serum theophylline levels. In addition, total serum levels can be used to reliably predict unbound serum levels. The use of mixed stimulated saliva is recommended as a reliable non-invasive method for monitoring unbound serum theophylline levels. The therapeutic range for saliva, which corresponds to the accepted total serum concentration range of 10-20 mg/L, is approximately 5.6-11.3 mg/L.
AB - Theophylline levels in mixed saliva (both stimulated and unstimulated) were compared with total and free (unbound) serum theophylline levels in 28 asthmatic outpatients using theophylline regularly. Stimulated saliva predicted both total and unbound serum theophylline concentrations within ± 1 μg/mL in 62.5% and 92.9%, respectively, of the samples examined. In addition, the total serum levels could be used to predict unbound serum concentrations to within ± 1 mg/L in 100% of the cases that were examined. These results indicate that saliva levels predict the unbound serum theophylline levels with greater accuracy and precision than they predict total serum theophylline levels. In addition, total serum levels can be used to reliably predict unbound serum levels. The use of mixed stimulated saliva is recommended as a reliable non-invasive method for monitoring unbound serum theophylline levels. The therapeutic range for saliva, which corresponds to the accepted total serum concentration range of 10-20 mg/L, is approximately 5.6-11.3 mg/L.
UR - http://www.scopus.com/inward/record.url?scp=0025875747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025875747&partnerID=8YFLogxK
U2 - 10.1002/j.1552-4604.1991.tb03739.x
DO - 10.1002/j.1552-4604.1991.tb03739.x
M3 - Article
C2 - 1880223
AN - SCOPUS:0025875747
SN - 0091-2700
VL - 31
SP - 565
EP - 570
JO - Journal of clinical pharmacology
JF - Journal of clinical pharmacology
IS - 6
ER -